盘点:Eur Radiol杂志近期(6-7月份)文献一览!

2017-10-01 shaosai MedSci原创

【盘点】Eur Radiol杂志近期(6-7月份)文献一览!

①Eur Radiol:对于服用激素的白血病患儿,利用MRI预测骨缺血坏死进展。

骨缺血坏死共同的病理机制是骨组织缺血,所以关于发病机制、血供受阻理论最易被人接受。这种理论认为,由于各种骨内、外致病因素引起骨组织营养血流减少、骨内血管网受压或流出静脉阻塞,造成局部血供障碍,严重者可引起骨组织缺血性坏死。病初可仅表现为单一主要血管受损,随着病情的发展,如残余循环血量不足以维持受损部位骨细胞正常供血需要时,骨髓组织将首先受损,随后出现骨细胞坏死。白血病患儿经类固醇治疗后会导致缺血性骨坏死。本研究旨在验证骨髓水肿能否作为缺血性骨坏死进展以及骨折的早期表现,并将结果发表在Eur Radiol上。

本研究共纳入了15例患儿和青少年白血病患者,并由两位放射学医师分析其骨骺ON的MR表现特点。利用Cochran-Mantel-Haenszel检验分析起初BME征象和软骨下骨折、疾病进展和骨塌陷的相关性。

47处骨坏死主要发生在承重关节,77%位于股骨。17处病变发生了骨塌陷,2处病变虽然没有出现骨塌陷但程度加重,28处病变无进展或有改善。BME与软骨下骨折(p=0.0014)、病情进展(p=0.0015)、骨塌陷显着相关(p<0.001),其中骨塌陷的敏感性和特异性分别为94%、77%。对有水肿的ON发生进展的时间约为2.7年(95% CI: 1.7-3.4),而大部分无水肿的ON多处于稳定状态(p=0.0011)。

本研究表明,BME可作为儿童和青少年白血病患者进展性ON和最终发生骨塌陷的早期MR征象。

②Eur Radiol:影像科医生临床科研技术贴!--比较体素内不相干运动扩散加权成像技术基于快速自旋回波和平面回波成像在头颈部成像的价值。

TSE序列主要是采取改变数据充填K-空间的方法,即将一个TR间期取得的多个回波的数据,同时放入一个K-空间。这样就有效地大大缩短扫描时间,所得图像也接近常规自旋回波序列所得的质量。TSE快速扫描序列的主要优点,除扫描时间比CSE缩短2~32倍,(甚至更多,主要取决于所选用的回波数目ET,即echotrain)外,图像的显示非常酷似CSE图像。FSE的T2WI图像质量高,运动性和磁化性伪影均较少。通过比较图像质量、表观扩散系数(ADC)和体素内不相干运动(IVIM)相关参数,来探讨快速自旋回波(TSE)-扩散加权成像(DWI)和平面回波成像(EPI)-DWI在头颈部应用的价值,并将结果发表在Eur Radiol上。

本研究共纳入了14名健康志愿者并行头颈部TSE-DWI和EPI-DWI成像。比较两种序列的失真率(DR)、信噪比(SNR)、对比噪声比(CNR)、ADC和IVIM相关参数。利用Bland-Altman分析法分析TES-DWI和EPI-DWI定量参数的可重复性。

结果为TSE-DWI的DR要明显小于EPI-DWI的DR。TSE-DWI的SNR和CNR要明显高于EPI-DWI。虽然差异没有统计学意义,但TSE-DWI的ADC和IVIM相关参数要高于EPI-DWI。Bland-Altman分析法表明两序列间有明显的差异。

本研究表明。TSE-DWI的图像质量要优于EPI-DWI,同时,TSE-DWI就有定量的不同参数。因此,TSE-DWI可作为EPI-DWI图像失真时的不二之选。然而,在临床工作中并不建议两种序列同时扫描。
(文章详见——Eur Radiol:影像科医生临床科研技术贴!--比较体素内不相干运动扩散加权成像技术基于快速自旋回波和平面回波成像在头颈部成像的价值。)

③Eur Radiol:CT灌注在评价胃癌影像学表现与病理学分型相关性的价值

胃癌根据组织学分类可以分为普通类型、特殊类型laurten's分型。普通的胃癌包括低分化腺癌、管状腺癌、印戒细胞癌、粘液腺癌和乳头状腺癌。根据病理分类分为早期胃癌和进展期胃癌。早期胃癌又分为隆起型胃癌、平坦性胃癌和凹陷性胃癌。进展期胃癌按组织分型为乳头状腺癌、管状腺癌、未分化癌、低分化癌、鳞癌、腺癌、类癌、粘液细胞癌和粘膜腺癌。本研究为了评价CT灌注参数与胃癌病理学亚分型的相关性,并将结果发表在Eur Radiol上。

本研究共纳入了46例术前行灌注CT(PCT)和根治性胃切除术的患者。分析PCT数据并由两位放射科医生独立评价并利用Kruskal-Wallis、Mann-Whitney U 检验和ROC分析比较各病理亚型间的差异性。利用组内相关系数(ICC)分析观察者间的一致性。

结果为,观察者间的一致性为中等-较好(ICC=0.585-0.678)。严重黏连的胃癌(PCC)的表面渗透值要明显高于其他类型(47.3 ml/100 g/min in PCC vs 26.5 ml/100 g/min in non-PCC,P<0.001)。PCC的平均通过时间(MTT)同样也比non-PCC的要长(13.0 s in PCC vs 10.3 s in non-PCC, P=0.032)。表面渗透性(P<0.001)和MTT (P=0.015)诊断PCC的曲线下面积为分别为0.891、0.697。

本研究表明,PCT中的灌注参数可以在胃癌患者中应用。因为PCC类型的表面渗透性和MTT值要明显高于non-PCC。因此,其可被用来在胃癌术前通过影像学来鉴别PCC类型的胃癌。

④Eur Radiol:单次激发快速自旋回波与多次激发平面回波成像技术扩散程度在鉴别眶内淋巴瘤和炎症的价值。

眼眶假瘤(pseudotumot of orbit)是一咱比较多见的眼眶病,占眼眶原发性肿瘤的第三位。可发生于不同年龄,男性病人较多,实质上属于一种慢性非特异性炎症。以其能引起眼球突出、眼球运动障碍等眼眶肿瘤所具有的症状而得名,故需要与眼眶淋巴瘤相签别。本研究旨在对比单次激发快速自旋回波扩散加权成像(TSE DWI)与多次激发平面回波扩散加权成像(MSh DWI)鉴别眶内淋巴瘤与炎性病变的价值,并将结果发表在Eur Radiol上。

本研究共纳入了29例经病理确认的淋巴瘤和39例炎性病变患者并行3.0T磁共振扫描。比较每处病变在TSE DWI和MSh DWI两种序列的ADC值。在常规磁共振图像上比较病变与正常灰质的信号比。

结果为淋巴瘤在TSE DWI上的ADC值 (0.68±0.14×10 -3 mm 2/s) 要明显低于炎性病变的ADC值(1.04±0.39×10 -3 mm 2/s; p<0.001). MSh DWI图像上的ADC值无法区分淋巴瘤和炎性病变(1.16±0.43×10-3 mm 2/s vs. 1.36±0.48×10 -3 mm 2/s; p=0.06). 常规磁共振检查也无法区分淋巴瘤和炎性病变 (p>0.05). ROC结果为TSE DWI 的ADC值是诊断淋巴瘤的最佳手段(TSE DWI AUC=0.831 vs. MSh DWI AUC=0.633)。

本研究表明,TSE DWI的ADC值有助于鉴别眶内淋巴瘤和炎性病变。

⑤Eur Radiol:比较MRI结合MRCP与超声内镜鉴别胰腺粘液性肿瘤良恶性的价值。

胰腺导管内乳头状黏液肿瘤(intraductal papillary mucinous neoplasm,IPMN)是一种较少见的胰腺囊性肿瘤。其起源于胰腺导管上皮,呈乳头状生长,分泌过多的黏液,引起主胰管和(或)分支胰管进行性扩张或囊变。IPMN好发于老年人,最多见于6o~7o岁,男女之比约2:1。临床症状和体征取决于导管扩张的程度和产生黏液的量。可表现为上腹部疼痛、乏力,也可因胰液流出受阻产生慢性胰腺炎甚至急性发作的临床表现。胰腺囊性肿瘤包括胰腺囊腺瘤和胰腺囊腺癌,比较少见。本研究为了比较MRI和超声内镜在鉴别IPMNs和恶性粘液性囊腺肿瘤(MCNs)良恶性的诊断价值并将结果发表在Eur Radiol。

本研究回顾性分析了55例行增强MRI和EUS的胰腺病变患者,其中有47例经手术确认的IPMNs(12恶性和35例良性)和8例MCNs(2例恶性和6例良性)。在EUS检查中并没有全部进行对比增强。由两名观察者独立评价MRIs,另外评价EUS图像。他们对每一种技术鉴别良恶性的诊断能力进行评分。利用ROC曲线(Az)评价诊断效能,计算准确率、敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)。

结果为,MRI的A z 要高于EUS的Az值 (0.712 和 0.688 for MRI vs. 0.543 for EUS; p = 0.007)。 两名观察者MRI诊断准确率 (74.5%)、特异性 (78.0% and 80.5%) 、PPV (50.0%) 要高于EUS(56.4%, 58.5% 和29.2%, respectively) (p = 0.013-0.049)。

本研究表明,MRI对鉴别胰腺IPMN和MCN的良恶性要优于EUS。

⑥Eur Radiol:血管内肿块经皮血管内活检在治疗前诊断的必要性和安全性

平滑肌肉瘤(leimyosarcoma)是起源于平滑肌的一种恶性肿瘤。常见于40岁以上男性,表现为单个偶或数个结节,直径不超过5cm,肿瘤预后与其存在位置和大小密切相关,皮下组织肿瘤主要来自血管。本研究为了评估经皮血管内活检在大血管充盈缺损病变的必要性和安全性,并将结果发表在Eur Radiol上。

本研究回顾性分析了自2004年3月至2014年11月的19例因IVLs行PEB的患者(年龄65±12岁,男11例,女8例)。所有PEB是为了早期诊断或对IVL定性以及怀疑IVL。术前影像学检查包括CT、MRI和或PET-CT。使用7F活检钳装置行PEB。对患者临床资料、手术操作安全性和结果及临床预后进行评价。

所有PEB操作成功(平均对每个IVL取两处组织标本)。无术中或术后并发症发生。在PEB后组织病理学给予确切的报告。在19例IVL中,14例为恶性(74%)。最常见的恶性病变为平滑肌肉瘤(29%)。良性病变(26%)主要3例血栓(肺动脉)和两例粘液瘤。

本研究表明,PEB是一种安全有效的操作,提供了一种能够获得组织标本的技术,从而对怀疑恶性病变的患者提供早期诊断。

⑦Eur Radiol:肝细胞肝癌肝癌切除术后肝衰竭怎么诊断?列线图的个体化预测价值!

肝衰竭是多种因素引起的严重肝脏损害,导致其合成、解毒、排泄和生物转化等功能发生严重障碍或失代偿,出现以凝血机制障碍和黄疸、肝性脑病、腹水等为主要表现的一组临床症候群。分为急性肝衰竭、亚急性肝衰竭、慢加急性(亚急性)肝衰竭和慢性肝衰竭四大类。临床表现为极度乏力,并有明显厌食、腹胀、恶心、呕吐等严重消化道症状。本研究为了提高列线图对预测可切除肝细胞肝癌(HCC)患者发生肝癌切除术后肝衰竭(PHLF)的临床应用价值,并将结果发表在Eur Radiol上。

列线图来自于2015.01-2015.12的136例可切除HCC并行肝癌切除术的患者数据。另有80例患者作为内部验证数据。利用一致性指数(C-index)、校准曲线来验证列线图的预测准确率和鉴别能力,并与常规预测手段相比。

结果为PHLF发生在30.9%的患者中,包括36例A级和6例B级肝癌患者。列线图是在血小板计数、血清胆红素、血清GGT、门脉高压和剪切波弹性摄影的临床体征的基础之上,具有很好的校准和辨别能力,C-indice为0.85。该模型在独立内部验证组表现出令人满意的拟合优度和鉴别能力,PHLF 的C-indices 为0.824。这种方法的ROC曲线下面积(AUC)要优于传统预测手段(相关C-indices为0.572-0.701)。

本研究表明,在患有可切除的HCC患者中,列线图能够在术前很好的预测PHLF。

⑧Eur Radiol:基于CT图像定量胸膜接触指数在评估早期NSCLC的预后和分子基础的价值

非小细胞肺癌(Non-small-cell carcinoma )与“非小细胞癌”同义,属于肺癌的一种,它包括鳞癌、腺癌、大细胞癌,与小细胞癌相比,其癌细胞生长分裂较慢,扩散转移相对较晚。非小细胞肺癌约占肺癌总敉的80-85% ,目前采用化疗的方式进行治疗。本研究为了评价基于CT图像胸膜接触指数(PCI)在早期非小细胞肺癌(NSCLC)的预测价值和分子基础,并将结果发表在Eur Radiol上。

本研究回顾性分析了7组NSCLC患者。定量PCI定义为在CT图像上经肿瘤直径校正后的肿瘤-胸膜接触面长度。分别评价发现组(n=117)PCI的预测价值和在另外一组NSCLC I级(n=88)进行验证。此外,利用另一组(n=89)患者验证PCI分子相关性和基因表达指标。为了进一步评价预测相关性,利用4组共775例I级患者和可利用的基因表达数据以及相关生存信息。

结果为,在阈值为0.8时,在两个成像队列中PCI分层患者总存活数(log-rank p?=?0.0076, 0.0304)。在与PCI相关基因细胞外基质(ECM)重构增加(p?=?0.0003)。调整年龄、性别和肿瘤分期,在基因表达组PCI基因组学替代物可独立预测总存活数(HR为1.46,p?=?0.0007)。

本研究表明,CT图像上胸膜接触指数与ECM重构相关,这也可作为早期NSCLC的非侵入性预后指标。

⑨Eur Radiol:梨状肌综合征:对116例患者的横断面影像学研究和治疗效果评价

坐骨神经盆腔出口狭窄症与梨状肌症候群,是发生在坐骨神经自骶丛神经分开后,在走经骨纤维管道离开骨盆达臀部之前,因局部病变所引起的嵌压综合征。前者病变主要位于盆腔出口周围,而后者主要是梨状肌本身病变所致。本研究为了通过报道横断面影像学表现、影像学研究和治疗结果对临床的影响增加临床对梨状肌综合征(PMs)认识的重要性,并将结果发表在Eur Radiol上。

在10年间,本研究共有116例通过影像学评价临床怀疑PMs的患者,并排除了具有相关症状的腰椎病变患者,回顾性分析了患者的MRI和或CT图像资料。评价梨状肌、坐骨神经(SN)、梨状肌区域和骶髂关节的影像学表现。根据先前报道的分类标准,将PMs分为原发性和继发性。记录治疗手段。利用3分评分法对治疗结果进行分类。

结果为,共有74例(63.8%)患者病理为PMs。其中有12例原发性和62例继发性。45.9%的患者表现PM肿胀,40.5% PM信号或密度异常,25.7%出现坐骨神经炎性病变。占位性病变是PMs的主要病理机制。在5/8的原发性和34/51的继发性PMs患者中治疗有效。在34例患者中,影像学提示未知的病变表现和改变治疗策略。

本研究表明,继发性PMs的病因具有多样性。对于怀疑PMs的患者,PM肿胀是最常见的影像学表现,也是占位性病变的主要原因之一。影像学有助于治疗策略的调整。

⑩Euro Radiol:超高b值扩散加权成像在诊断前列腺癌的价值,是否有取代增强MRI扫描的可能性呢?

前列腺癌是人类特有的疾病,在欧美是男性最常见的恶性肿瘤之一,在美国前列腺癌发病率占第1位,死亡率仅次于肺癌。中国、日本、印度等亚洲国家前列腺癌发病率远低于欧美,但有增长趋势。本研究为了评价T2WI和超高b值(b=2000 s/mm2)扩散加权成像序列在不同年资放射科医生诊断前列腺癌(Pca)的准确性,并将结果发表在Euro Radiol上。

本研究共纳入了93例怀疑Pca的患者。对于b2000,2D空间选择射频脉冲采用平面回波传输轨道,扫描视野(FOV)减小到1/3。所有3位阅片者独立地评价DWI图像来分析是否有可疑病变出现异常高信号。将结果与组织病理学比较。

结果为,共发现62例Pca患者。阅片者将1例明显的Pca病灶(Gleason评分 (GS) 7b)遗漏。总的来说,敏感性、特异性、阳性预测值、阴性预测值在阅片者A、B、C分别为90/71/86/79% ,87/84/92/76%, 85/74/87/72%。明显Pca发现率在阅片者A、B、C分别为100/100/94%。观察者间的一致性良好(Kappa A/B: 0.8; A/C: 0.82; B/C: 0.74)。

本研究表明,超高b值DWI结合T2W在发现临床上明显Pca是非常有帮助的。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=251394, encodeId=b246251394a1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K4PNicOvbHfgIficrsEKztlD5yv1UnCFhnFmFU9yv1RHLflMRibWrppbsiccfMB8tT9HCkAr3zL2zVml/0, createdBy=89da1604922, createdName=䖝二, createdTime=Sun Oct 08 21:23:23 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251275, encodeId=0e972512e507, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Oct 08 07:43:02 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250241, encodeId=41a52502415a, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Oct 04 08:49:23 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249635, encodeId=02852496358c, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Oct 02 08:41:19 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249629, encodeId=276d24962901, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Oct 02 08:39:26 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249599, encodeId=8b2e24959953, content=内容新颖.好好看下, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Oct 02 07:42:53 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249560, encodeId=d08d249560c7, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Mon Oct 02 07:05:54 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249528, encodeId=d21324952846, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Oct 02 05:53:43 CST 2017, time=2017-10-02, status=1, ipAttribution=)]
    2017-10-08 䖝二

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=251394, encodeId=b246251394a1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K4PNicOvbHfgIficrsEKztlD5yv1UnCFhnFmFU9yv1RHLflMRibWrppbsiccfMB8tT9HCkAr3zL2zVml/0, createdBy=89da1604922, createdName=䖝二, createdTime=Sun Oct 08 21:23:23 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251275, encodeId=0e972512e507, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Oct 08 07:43:02 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250241, encodeId=41a52502415a, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Oct 04 08:49:23 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249635, encodeId=02852496358c, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Oct 02 08:41:19 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249629, encodeId=276d24962901, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Oct 02 08:39:26 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249599, encodeId=8b2e24959953, content=内容新颖.好好看下, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Oct 02 07:42:53 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249560, encodeId=d08d249560c7, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Mon Oct 02 07:05:54 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249528, encodeId=d21324952846, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Oct 02 05:53:43 CST 2017, time=2017-10-02, status=1, ipAttribution=)]
    2017-10-08 Y—xianghai

    学习了新知识

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=251394, encodeId=b246251394a1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K4PNicOvbHfgIficrsEKztlD5yv1UnCFhnFmFU9yv1RHLflMRibWrppbsiccfMB8tT9HCkAr3zL2zVml/0, createdBy=89da1604922, createdName=䖝二, createdTime=Sun Oct 08 21:23:23 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251275, encodeId=0e972512e507, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Oct 08 07:43:02 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250241, encodeId=41a52502415a, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Oct 04 08:49:23 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249635, encodeId=02852496358c, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Oct 02 08:41:19 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249629, encodeId=276d24962901, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Oct 02 08:39:26 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249599, encodeId=8b2e24959953, content=内容新颖.好好看下, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Oct 02 07:42:53 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249560, encodeId=d08d249560c7, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Mon Oct 02 07:05:54 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249528, encodeId=d21324952846, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Oct 02 05:53:43 CST 2017, time=2017-10-02, status=1, ipAttribution=)]
    2017-10-04 大爰

    学习了谢谢分享!!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=251394, encodeId=b246251394a1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K4PNicOvbHfgIficrsEKztlD5yv1UnCFhnFmFU9yv1RHLflMRibWrppbsiccfMB8tT9HCkAr3zL2zVml/0, createdBy=89da1604922, createdName=䖝二, createdTime=Sun Oct 08 21:23:23 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251275, encodeId=0e972512e507, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Oct 08 07:43:02 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250241, encodeId=41a52502415a, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Oct 04 08:49:23 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249635, encodeId=02852496358c, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Oct 02 08:41:19 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249629, encodeId=276d24962901, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Oct 02 08:39:26 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249599, encodeId=8b2e24959953, content=内容新颖.好好看下, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Oct 02 07:42:53 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249560, encodeId=d08d249560c7, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Mon Oct 02 07:05:54 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249528, encodeId=d21324952846, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Oct 02 05:53:43 CST 2017, time=2017-10-02, status=1, ipAttribution=)]
    2017-10-02 Y—xianghai

    学习了新知识

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=251394, encodeId=b246251394a1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K4PNicOvbHfgIficrsEKztlD5yv1UnCFhnFmFU9yv1RHLflMRibWrppbsiccfMB8tT9HCkAr3zL2zVml/0, createdBy=89da1604922, createdName=䖝二, createdTime=Sun Oct 08 21:23:23 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251275, encodeId=0e972512e507, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Oct 08 07:43:02 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250241, encodeId=41a52502415a, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Oct 04 08:49:23 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249635, encodeId=02852496358c, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Oct 02 08:41:19 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249629, encodeId=276d24962901, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Oct 02 08:39:26 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249599, encodeId=8b2e24959953, content=内容新颖.好好看下, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Oct 02 07:42:53 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249560, encodeId=d08d249560c7, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Mon Oct 02 07:05:54 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249528, encodeId=d21324952846, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Oct 02 05:53:43 CST 2017, time=2017-10-02, status=1, ipAttribution=)]
    2017-10-02 龙胆草

    学习谢谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=251394, encodeId=b246251394a1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K4PNicOvbHfgIficrsEKztlD5yv1UnCFhnFmFU9yv1RHLflMRibWrppbsiccfMB8tT9HCkAr3zL2zVml/0, createdBy=89da1604922, createdName=䖝二, createdTime=Sun Oct 08 21:23:23 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251275, encodeId=0e972512e507, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Oct 08 07:43:02 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250241, encodeId=41a52502415a, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Oct 04 08:49:23 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249635, encodeId=02852496358c, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Oct 02 08:41:19 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249629, encodeId=276d24962901, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Oct 02 08:39:26 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249599, encodeId=8b2e24959953, content=内容新颖.好好看下, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Oct 02 07:42:53 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249560, encodeId=d08d249560c7, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Mon Oct 02 07:05:54 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249528, encodeId=d21324952846, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Oct 02 05:53:43 CST 2017, time=2017-10-02, status=1, ipAttribution=)]
    2017-10-02 忠诚向上

    内容新颖.好好看下

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=251394, encodeId=b246251394a1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K4PNicOvbHfgIficrsEKztlD5yv1UnCFhnFmFU9yv1RHLflMRibWrppbsiccfMB8tT9HCkAr3zL2zVml/0, createdBy=89da1604922, createdName=䖝二, createdTime=Sun Oct 08 21:23:23 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251275, encodeId=0e972512e507, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Oct 08 07:43:02 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250241, encodeId=41a52502415a, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Oct 04 08:49:23 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249635, encodeId=02852496358c, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Oct 02 08:41:19 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249629, encodeId=276d24962901, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Oct 02 08:39:26 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249599, encodeId=8b2e24959953, content=内容新颖.好好看下, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Oct 02 07:42:53 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249560, encodeId=d08d249560c7, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Mon Oct 02 07:05:54 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249528, encodeId=d21324952846, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Oct 02 05:53:43 CST 2017, time=2017-10-02, status=1, ipAttribution=)]
    2017-10-02 明月清辉

    谢谢分享.学习了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=251394, encodeId=b246251394a1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K4PNicOvbHfgIficrsEKztlD5yv1UnCFhnFmFU9yv1RHLflMRibWrppbsiccfMB8tT9HCkAr3zL2zVml/0, createdBy=89da1604922, createdName=䖝二, createdTime=Sun Oct 08 21:23:23 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251275, encodeId=0e972512e507, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Oct 08 07:43:02 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250241, encodeId=41a52502415a, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Oct 04 08:49:23 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249635, encodeId=02852496358c, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Oct 02 08:41:19 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249629, encodeId=276d24962901, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Oct 02 08:39:26 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249599, encodeId=8b2e24959953, content=内容新颖.好好看下, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Oct 02 07:42:53 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249560, encodeId=d08d249560c7, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Mon Oct 02 07:05:54 CST 2017, time=2017-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249528, encodeId=d21324952846, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Oct 02 05:53:43 CST 2017, time=2017-10-02, status=1, ipAttribution=)]
    2017-10-02 刘煜

    谢谢分享.学习了

    0

相关资讯

Eur Heart J:房颤者中断用华法林 血栓栓塞风险升高

12月23日,丹麦学者在Eur Heart J发表的一项研究"Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation"表明,在房颤患者中,中断华法林治疗与治疗中断后前90天内的死亡或血栓-栓

Eur J Pharmacol:补骨脂二氢黄酮甲醚Bavachinin可作为抑制肿瘤血管生成的治疗剂

缺氧诱导因子1(HIF-1)有两个亚基,在缺氧情况下,HIF-1α会过度表达,HIF-1α转录活性的增加与肿瘤进展、血管生成、转移和侵袭密切相关。 近日European Journal of Pharmacology杂志上的一则研究证实天然化合物补骨脂二氢黄酮甲醚 Bavachinin在体外和体内有较强的抗血管生成活性。Bavachinin浓度依赖性抑制人KB癌(HeLa细胞的衍生细胞株)HIF